- Investing Ideas
- Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
41
Companies which are more than 50% undervalued based on analyst price target.
41 companies
Bonesupport Holding
Market Cap: SEK 14.7b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 222.60
7D
3.6%
1Y
-31.1%
Swedencare
Market Cap: SEK 3.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 21.90
7D
0.2%
1Y
-40.9%
Hansa Biopharma
Market Cap: SEK 3.4b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 33.40
7D
-9.9%
1Y
9.1%
Vicore Pharma Holding
Market Cap: SEK 3.1b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 11.08
7D
0%
1Y
17.0%
Egetis Therapeutics
Market Cap: SEK 3.0b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 6.38
7D
-3.0%
1Y
13.3%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 23.05
7D
-1.3%
1Y
-38.8%
Cereno Scientific
Market Cap: SEK 1.5b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 4.78
7D
-0.8%
1Y
-49.7%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.10
7D
-5.7%
1Y
-26.5%
Medivir
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.80
7D
-0.4%
1Y
-6.9%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 19.10
7D
11.3%
1Y
-4.0%
BICO Group
Market Cap: SEK 1.1b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 14.88
7D
2.8%
1Y
-57.9%
AlzeCure Pharma
Market Cap: SEK 868.8m
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 6.30
7D
-0.6%
1Y
70.3%
Xspray Pharma
Market Cap: SEK 787.1m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 16.60
7D
2.1%
1Y
-67.6%
Oncopeptides
Market Cap: SEK 632.5m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.60
7D
-0.4%
1Y
-66.7%
Cinclus Pharma Holding
Market Cap: SEK 556.6m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 11.96
7D
-1.6%
1Y
-32.7%
Orexo
Market Cap: SEK 513.3m
A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 14.70
7D
-2.6%
1Y
-28.3%
FluoGuide
Market Cap: SEK 506.8m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 31.00
7D
-1.6%
1Y
-25.3%
Corline Biomedical
Market Cap: SEK 458.6m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 17.55
7D
0%
1Y
35.0%
Cantargia
Market Cap: SEK 447.5m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.80
7D
-3.7%
1Y
-42.9%
Mendus
Market Cap: SEK 437.8m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 6.87
7D
-0.3%
1Y
-14.1%
Intervacc
Market Cap: SEK 430.1m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 1.26
7D
1.4%
1Y
25.9%
Isofol Medical
Market Cap: SEK 257.7m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.80
7D
1.8%
1Y
-9.6%
Alzinova
Market Cap: SEK 211.2m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.04
7D
1.2%
1Y
-30.3%
IRLAB Therapeutics
Market Cap: SEK 197.2m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other central nervous system (CNS) disorders in the United States.
IRLAB A
SEK 1.33
7D
7.6%
1Y
-57.2%
KDventures
Market Cap: SEK 160.9m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDV B
SEK 0.24
7D
0.2%
1Y
-75.5%
Initiator Pharma
Market Cap: SEK 160.9m
A clinical-stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous systems.
INIT
SEK 2.35
7D
3.5%
1Y
-30.1%
Elicera Therapeutics
Market Cap: SEK 156.8m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.35
7D
-0.8%
1Y
-61.7%
Nanologica
Market Cap: SEK 149.6m
A life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally.
NICA
SEK 0.46
7D
1.1%
1Y
-73.2%
Active Biotech
Market Cap: SEK 139.2m
A biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden.
ACTI
SEK 5.28
7D
2.5%
1Y
-72.5%
NextCell Pharma
Market Cap: SEK 133.0m
A biopharmaceutical company, engages in the research, development, and manufacture of stromal cell therapies in Sweden.
NXTCL
SEK 1.05
7D
-1.5%
1Y
-11.3%
Vivesto
Market Cap: SEK 98.8m
Develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 8.92
7D
1.9%
1Y
-61.0%
IDL Diagnostics
Market Cap: SEK 89.4m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.39
7D
-9.8%
1Y
-31.9%
OncoZenge
Market Cap: SEK 89.1m
A clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 6.34
7D
-8.2%
1Y
3.6%
Annexin Pharmaceuticals
Market Cap: SEK 88.2m
A clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 12.50
7D
0%
1Y
-59.7%
Ascelia Pharma
Market Cap: SEK 80.8m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.60
7D
16.8%
1Y
-88.1%
Spago Nanomedical
Market Cap: SEK 76.1m
A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.
SPAGO
SEK 0.12
7D
1.3%
1Y
-60.9%